Lichen Nitidus Treatment Market - Global Forecast Till 2027

Lichen Nitidus Treatment Market Information: By Type (Topical, Oral), By Treatment (Corticosteroids, Retinoid, Antihistamines, Phototherapy, Others), By End Users (Hospitals, Dermatology Clinics, Others) - Global Forecast Till 2027

ID: MRFR/Pharma/2896-HCR | February 2021 | Region: Global | 200 pages

Global Lichen Nitidus Treatment Market Market Scenario

Lichen nitidus is a rare, chronic skin disease characterized by flat-topped, and skin-colored micropapules. Characteristics of these micropapules are the size, shape (pin point), color, location and itching. It mostly affects geriatric and pediatric population. They commonly occur on the chest, abdomen, arms and genital areas, including the penis. In this disease, T lymphocytes get activated resulting in the formation of these micropapules. In lichen nitidus, linear arrangement of micropapules can be seen on the fore arm or affected area.


 Increasing prevalence of skin diseases across the globe is the major factor contributing the growth of the market. Unawareness about rare skin diseases among people may act as a restrain for the market growth.


The global lichen nitidus treatment market is expected to grow at a CAGR of 8.7% during the forecast period and is estimated to reach USD 170 million by 2023.


Segments          

The global lichen nitidus treatment market is segmented on the basis of types, which includes oral and topical treatment. On the basis of treatment, the market is segmented into corticosteroids, retinoid, antihistamines, phototherapy and other treatment. On the basis of end user, the market is segmented into hospitals, dermatology clinics, and others.


Regional Analysis of the Global Lichen Nitidus Treatment Market      The Americas accounts for the largest share of the global lichen nitidus treatment market due to increasing prevalence of skin disease, availability of treatment methods at affordable cost and demand for new topical products for its treatment. According to the American Osteopathic College of Dermatology, the number of people suffering from lichen nitidus is increasing at a steady rate in American countries. It also stated that in 2013, USD 75 billion were spent on the treatment of various skin diseases. Aging population is another factor responsible for the market growth in these countries.


Europe is the second largest market that holds a noticeable share of the global lichen nitidus treatment market owing to an increase in the awareness regarding skin diseases, demand for skin care cosmetics, and growing market for dermatology in many European countries.


In Asia Pacific, the market is driven by increasing in number of dermatology clinics, rising demand for evidence based skin care and increasing prevalence of diseases associated with lichen nitidus such as atopic dermatitis and tuberculosis.


The Middle East & Africa is expected to show a steady but positive growth in this market due constant demand for diagnostics services in dermatology, rising awareness about lichen nitidus among children and its prevention.


Figure 1 Global Lichen Nitidus Treatment Market by type, 2016 (%) Global Lichen Nitidus Treatment Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation 


Intended Audience



  • Medical Device Manufacturers

  • Medical Device Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Research Methodology Lichen Nitidus Treatment Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Key Players in the Global Lichen nitidus treatment Market                

Some of the key players in this market are Pfizer Inc. (U.S), Novartis AG (Switzerland), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S), Sanofi (France), GlaxoSmithKline plc. (U.K), AstraZeneca (U.K), Hubei Gedian Humanwell Pharmaceutical Co.,Ltd (China), Farmabios SPA (Italy), Horizon Pharma plc. (Ireland).    


The report on the global lichen nitidus treatment market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions



Frequently Asked Questions (FAQ) :


Increasing cases of skin diseases play a crucial role in the Lichen Nitidus Treatment Market.

The Lichen Nitidus Treatment Market would USD 170 million by 2023.

The Americas would drive the Lichen Nitidus Treatment Market ahead.

Retinoid, antihistamines, phototherapy, corticosteroids, and other treatment segments that have been discussed in the report.

Brief TOC

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain

5.3 Investment Feasibility Analysis

5.4 Price Factor Analysis

6 Global Lichen Nitidus Treatment Market, by Type

6.1 Introduction

6.2 Topical

6.3 Oral

7 Global Lichen Nitidus Treatment Market, by Treatment

7.1 Introduction

7.2 Corticosteroids

7.3 Retinoid

7.4 Antihistamines

7.5 Others

8 Global Lichen Nitidus Treatment Market, by End User

8.1 Introduction

8.2 Hospitals

8.3 Dermatology Clinics

8.4 Others

9 Global Lichen Nitidus Treatment Market by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 Latin America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 UK

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Republic of Korea

9.4.5 Australia

9.4.6 Rest of Asia Pacific

9.5 Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of Middle East & Africa

10 Company Landscape

10.1 Introduction

10.2 Market share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

11 Company Profiles

11.1 Pfizer Inc.

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Novartis AG

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Merck Sharp & Dohme Corp.

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Sanofi

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 GlaxoSmithKline plc.

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 AstraZeneca

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 Hubei Gedian Humanwell Pharmaceutical Co. Ltd.

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Healthcare Industry

13 Appendix